Weight Loss

Making sense of today’s weightloss treatments…

Buying Weight Loss Treatment Online

The number and variety of weight loss treatment options available has exploded in the last few years with innovative medications delivering results never before seen. New drugs such as Mounjaro and Wegovy have transformed the weight loss treatment landscape. 

Use this page as a guide to steer you towards treatment that may be best for you. Visit the 

  • Receptor agonists like tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda), which promote satiety and slow gastric emptying.
  • Fat blockers like orlistat (Xenical).
  • Combination drugs like bupropion-naltrexone (Mysimba) for craving reduction.

Our Guarantees

Medications are dispensed by EU Registered Pharmacies. Medical consultations are performed by EU registered doctors.

Weight loss medications work by various mechanisms such as suppressing appetite, reducing fat absorption, or mimicking hormones to regulate blood sugar and fullness.

GLP-1 receptor agonists

These medications, such as semaglutide (Wegovy), liraglutide (Saxenda), and dual GLP-1/GIP agonists like tirzepatide (Mounjaro), are injectable medications that mimic the effects of hormones naturally produced in the body. They work by making you feel full sooner by slowing down the emptying of the stomach and regulating blood sugar levels. These drugs have shown 15-21% body weight reduction over a year when combined with lifestyle changes.

Fat Blockers

Fat blockers, like orlistat (Xenical), function by inhibiting the enzyme lipase in the digestive tract, which prevents the absorption of about 25-30% of dietary fats consumed. This unabsorbed fat is then excreted, leading to gradual weight loss when paired with a reduced-calorie, low-fat diet, with users often experiencing 5-10% reduction in body weight over six months to a year. Orlistat is generally considered safer for long-term use compared to other options.

Combination Drugs

Combination drugs for weight loss, such as bupropion-naltrexone (Mysimba), pair two active ingredients to target multiple aspects of appetite and craving control simultaneously. Bupropion boosts mood-related neurotransmitters to help suppress appetite, while naltrexone blocks opioid receptors to reduce food cravings and emotional eating. These medications are typically prescribed for long-term use, with average weight loss of 5-10%.